BioForce on Target for Nano eNabler(TM) Placements

Aug 14, 2006, 01:00 ET from BioForce Nanosciences

    AMES, Iowa, Aug. 14 /PRNewswire-FirstCall/ -- BioForce Nanosciences
 (OTC Bulletin Board:   BFNH) has announced a new brand name for the company's
 core technology to complement and coincide with the target placement of
 twenty customer units in 2006. BioForce has placed five units with
 customers, with another five installations scheduled for the third quarter
 and is on track to meet its target, the company said.
     BioForce has developed a benchtop molecular printing system that places
 tiny domains of biological materials on surfaces with nanometer spatial
 precision. Previously called the NanoArrayer, it now will be known as the
 Nano eNabler(TM).
     "The Nano eNabler brand name is an excellent description of the
 capabilities our benchtop molecular printing technology provides our
 customers," said Michael Lynch, product manager. "The feedback we have
 received from our clients makes this transition to a new brand name an easy
 decision. Our clients are using the BioForce technology to enable biosensor
 printing, stem cell studies and tissue engineering, to name a few uses."
     "This rebranding effort complements our continued plan to develop 20
 Nano eNabler customer sites this year," said Kerry Frey, chief operations
 officer. "I am very pleased that we are on track to meet this placement
 goal by the end of 2006."
     "BioForce identifies and qualifies each new technology evaluation site
 to provide the company with valuable third party feedback on the Nano
 eNabler performance," said Eric Henderson, founder and chief executive
 officer. "Information on the value of the Nano eNabler brand for these
 emerging bionanotechnology applications is important to BioForce as we
 continue to market our technology."
     About BioForce Nanosciences, Inc.
     BioForce Nanosciences is a nanotechnology tools and applications
 company, providing innovative and practical products that support the
 growth of the nanotechnology industry. The company has spent more than a
 decade of invention, research and development on patented and
 patent-pending nanotechnology products. The core technology is the Nano
 eNabler(TM) Benchtop Molecular Printer, a portal to new opportunities in
 nanotechnology. The Nano eNabler opens the door to new and important
 applications in the biomedical and life sciences markets that lead to
 improved quality of life. BioForce continues to target inventions that
 further expand the reach of its proprietary technology and expand its
 robust patent, trademark and IP portfolio.
     BioForce Nanosciences, Inc., the Practical Nanotechnology(TM) company
 brings inventions to the marketplace that complement existing innovations,
 licensing and acquisitions. BioForce is a wholly owned subsidiary of
 BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board:   BFNH). For more
 information, visit
     This news release contains forward-looking information that may be
 affected by certain risks and uncertainties, including those risks and
 uncertainties described in the company's most recent filings with the
 Securities and Exchange Commission. The company's actual results could
 differ materially from such forward-looking statements. We assume no duty
 to update these statements at any future date.

SOURCE BioForce Nanosciences